Dennis Church

This inventor holds 18 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Merck Serono S. a., Laboratoires Serono S.a., Applied Research Systems Ars Holding N.v.. Active years: 2004-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis Church. Retrieved from https://idiyas.com/inventor/dennis-church

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 2)

% Patents Active = 16.7

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 1)

Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 91(Granted Patents)

Location History:

Commungy, CH (2008)
Commungny, FR (2011)
Commugny, CH (2004 - 2014)

Company Filing History:

Laboratoires Serono S.a.

patents

2 out of 156

Applied Research Systems Ars Holding N.v.

patents

4. 1 out of 10

Laboratories Serono Sa

patents

Years Active: 2004-2014

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8877757 - Pyrazine derivatives and use as PI3K inhibitors (2014-11-04),

2. 8410110 - 9-(piperazinylalkyl) carbazoles as Bax-modulators (2013-04-02),

3. 8236963 - Tricyclic spiro derivatives as CRTH2 modulators (2012-08-07),

4. 8106214 - 2-imino-4-(thio) oxo-5-polycyclovinylazolines for use as PI3 kinase inhibitors (2012-01-31),

5. 8071597 - Pyrazine compounds and uses as PI3K inhibitors (2011-12-06),

6. 8053436 - 9-(piperazinylalkyl) carbazoles as bax-modulators (2011-11-08),

7. 8017628 - Pharmaceutically active sulfonyl hydrazide derivatives (2011-09-13),

8. 8012995 - Pharmaceutically active sulfonamide derivatives (2011-09-06),

9. 8008341 - Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases (2011-08-30),

10. 7846925 - Azolidinone-vinyl fused-benzene derivatives (2010-12-07),

11. 7638538 - Pharmaceutically active sulfonyl amino acid derivatives (2009-12-29),

12. 7544700 - Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein JunKinases (2009-06-09),

13. 7470686 - Method of inhibiting the expression and/or the activity of JNK (2008-12-30),

14. 7432286 - Pharmaceutically active sulfonyl hydrazide derivatives (2008-10-07),

15. 7417058 - Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases (2008-08-26),

Title: The Innovative Journey of Dennis Church

Introduction: Dennis Church, a visionary inventor hailing from Commugny, Switzerland, has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Dennis Church holds several patents in the areas of renewable energy technologies, sustainable transportation solutions, and advanced materials science. His most recent patent involves a revolutionary method for harnessing solar energy more efficiently.

Career Highlights: Throughout his illustrious career, Dennis Church has worked with leading research institutions and technology companies to bring his inventions to life. He has been recognized for his innovative approach to solving complex challenges in the industry.

Collaborations: Dennis Church has collaborated with top engineers, scientists, and designers from around the world to develop cutting-edge solutions that have the potential to shape the future of technology. His collaborative spirit has been instrumental in the success of many projects.

Conclusion: In conclusion, Dennis Church's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His dedication to creating a more sustainable and technologically advanced future continues to inspire generations to come.

Profile summary based on public USPTO records.